Literature DB >> 20395647

Access to care and the incidence of endstage renal disease due to systemic lupus erythematosus.

Michael M Ward1.   

Abstract

OBJECTIVE: Persons with low socioeconomic status have an increased risk of endstage renal disease (ESRD) due to systemic lupus erythematosus (SLE), possibly because of limited access to care. We examined if the incidence of ESRD due to SLE was higher in geographic areas with poorer access to care.
METHODS: In this population-based ecological study, we tested associations between the incidence of ESRD due to SLE and the proportion of hospitalizations with no insurance, Medicaid or managed care insurance, residence in a primary care-provider shortage area or rural area, and rate of hospitalizations for ambulatory care-sensitive conditions, by ZIP code in California in 1999-2004.
RESULTS: The incidence of ESRD due to SLE was higher in ZIP codes with higher proportions of hospitalizations with no insurance (r = 0.22, p < 0.0001) or Medicaid (r = 0.21, p < 0.0001), and in ZIP codes with higher rates of hospitalizations for ambulatory care-sensitive conditions (r = 0.23, p < 0.0001). In multivariate analyses, incidences were higher in ZIP codes with higher proportions of hospitalizations with Medicaid (p < 0.0001) and higher rates of hospitalizations for ambulatory care-sensitive conditions (p = 0.06), independent of the socioeconomic status of the ZIP code residents.
CONCLUSION: The incidence of ESRD due to SLE is higher in areas with higher proportions of residents who have public insurance and higher rates of avoidable hospitalizations, suggesting that limited access to care may contribute to this complication of SLE.

Entities:  

Mesh:

Year:  2010        PMID: 20395647      PMCID: PMC2952403          DOI: 10.3899/jrheum.091199

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  27 in total

1.  Trends in physician participation in Medicaid. The California experience.

Authors:  Andrew B Bindman; Jean Yoon; Kevin Grumbach
Journal:  J Ambul Care Manage       Date:  2003 Oct-Dec

2.  Revisiting the behavioral model and access to medical care: does it matter?

Authors:  R M Andersen
Journal:  J Health Soc Behav       Date:  1995-03

3.  Bias in the coding of hospital discharge data and its implications for quality assessment.

Authors:  P S Romano; D H Mark
Journal:  Med Care       Date:  1994-01       Impact factor: 2.983

4.  The association of socio-economic status, race, psychosocial factors and outcome in patients with systemic lupus erythematosus.

Authors:  N Sutcliffe; A E Clarke; C Gordon; V Farewell; D A Isenberg
Journal:  Rheumatology (Oxford)       Date:  1999-11       Impact factor: 7.580

5.  Medicaid and access to care among persons with systemic lupus erythematosus.

Authors:  JoAnn Zell Gillis; Jinoos Yazdany; Laura Trupin; Laura Julian; Pantelis Panopalis; Lindsey A Criswell; Patricia Katz; Edward Yelin
Journal:  Arthritis Rheum       Date:  2007-05-15

6.  Morbidity of systemic lupus erythematosus: role of race and socioeconomic status.

Authors:  M Petri; S Perez-Gutthann; J C Longenecker; M Hochberg
Journal:  Am J Med       Date:  1991-10       Impact factor: 4.965

7.  Rates of avoidable hospitalization by insurance status in Massachusetts and Maryland.

Authors:  J S Weissman; C Gatsonis; A M Epstein
Journal:  JAMA       Date:  1992-11-04       Impact factor: 56.272

8.  Factors associated with refractory renal disease in patients with systemic lupus erythematosus: the role of patient nonadherence.

Authors:  I N Bruce; D D Gladman; M B Urowitz
Journal:  Arthritis Care Res       Date:  2000-12

9.  Improved clinical outcome of lupus nephritis during the past decade: importance of early diagnosis and treatment.

Authors:  C Fiehn; Y Hajjar; K Mueller; R Waldherr; A D Ho; K Andrassy
Journal:  Ann Rheum Dis       Date:  2003-05       Impact factor: 19.103

10.  Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients.

Authors:  Ricard Cervera; Munther A Khamashta; Josep Font; Gian Domenico Sebastiani; Antonio Gil; Paz Lavilla; Juan Carlos Mejía; A Olcay Aydintug; Hanna Chwalinska-Sadowska; Enrique de Ramón; Antonio Fernández-Nebro; Mauro Galeazzi; Merete Valen; Alessandro Mathieu; Frédéric Houssiau; Natividad Caro; Paula Alba; Manuel Ramos-Casals; Miguel Ingelmo; Graham R V Hughes
Journal:  Medicine (Baltimore)       Date:  2003-09       Impact factor: 1.889

View more
  20 in total

1.  Quality of care for incident lupus nephritis among Medicaid beneficiaries in the United States.

Authors:  Jinoos Yazdany; Candace H Feldman; Jun Liu; Michael M Ward; Michael A Fischer; Karen H Costenbader
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-04       Impact factor: 4.794

2.  Healthcare quality in systemic lupus erythematosus: using Donabedian's conceptual framework to understand what we know.

Authors:  Erica F Lawson; Jinoos Yazdany
Journal:  Int J Clin Rheumtol       Date:  2012-02

3.  Impact of the Affordable Care Act Medicaid Expansion on Access to Care and Hospitalization Charges for Lupus Patients.

Authors:  Elizabeth A Brown; Clara E Dismuke-Greer; Viswanathan Ramakrishnan; Trevor D Faith; Edith M Williams
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-02       Impact factor: 4.794

4.  Influence of ethnicity on childhood-onset systemic lupus erythematosus: results from a multiethnic multicenter Canadian cohort.

Authors:  Deborah M Levy; Christine A Peschken; Lori B Tucker; Gaëlle Chédeville; Adam M Huber; Janet E Pope; Earl D Silverman
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-01       Impact factor: 4.794

5.  Comparative Rates of Serious Infections Among Patients With Systemic Lupus Erythematosus Receiving Immunosuppressive Medications.

Authors:  Candace H Feldman; Francisco M Marty; Wolfgang C Winkelmayer; Hongshu Guan; Jessica M Franklin; Daniel H Solomon; Karen H Costenbader; Seoyoung C Kim
Journal:  Arthritis Rheumatol       Date:  2017-02       Impact factor: 10.995

6.  European genetic ancestry is associated with a decreased risk of lupus nephritis.

Authors:  Ilana B Richman; Kimberly E Taylor; Sharon A Chung; Laura Trupin; Michelle Petri; Edward Yelin; Robert R Graham; Annette Lee; Timothy W Behrens; Peter K Gregersen; Michael F Seldin; Lindsey A Criswell
Journal:  Arthritis Rheum       Date:  2012-10

Review 7.  Insights into the epidemiology and management of lupus nephritis from the US rheumatologist's perspective.

Authors:  Paul J Hoover; Karen H Costenbader
Journal:  Kidney Int       Date:  2016-06-22       Impact factor: 10.612

8.  Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004.

Authors:  Candace H Feldman; Linda T Hiraki; Jun Liu; Michael A Fischer; Daniel H Solomon; Graciela S Alarcón; Wolfgang C Winkelmayer; Karen H Costenbader
Journal:  Arthritis Rheum       Date:  2013-03

9.  Examining Racial Differences in Access to Primary Care for People Living with Lupus: Use of Ambulatory Care Sensitive Conditions to Measure Access.

Authors:  Elizabeth A Brown; Mulugeta Gebregziabher; Diane L Kamen; Brandi M White; Edith M Williams
Journal:  Ethn Dis       Date:  2020-09-24       Impact factor: 1.847

Review 10.  Use of Quality Measures to Identify Disparities in Health Care for Systemic Lupus Erythematosus.

Authors:  Shilpa Arora; Jinoos Yazdany
Journal:  Rheum Dis Clin North Am       Date:  2020-09-09       Impact factor: 2.670

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.